Gilde Healthcare company Zetacom acquires communication specialist Ooperon - Gilde Healthcare

Gilde Healthcare company Zetacom acquires communication specialist Ooperon

July 11, 2022
Utrecht (the Netherlands)

Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.

Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.. Ooperon provides specialist solutions for critical communication in healthcare and personal security. The add-on of Ooperon marks Zetacom’s third acquisition since the addition of communication solutions providers Creaforti and BproCare. By joining forces, Zetacom strengthens its position as a market-leading IT partner in healthcare while Ooperon can support its customers with a more complete range of solutions. Ooperon will continue to operate as an independent subsidiary producing and marketing communication solutions for healthcare and correctional facilities.

About Zetacom
Zetacom (Zoetermeer, The Netherlands) is the ICT-specialist and system integrator for the Dutch healthcare sector. Zetacom supports hospitals in their transformation to smart hospitals as well as healthcare institutions, government and business markets. Zetacom supports the (healthcare) chain function with intelligent ICT solutions. The extensive service offering and experience as a market-leading system integrator enable clients to improve their managerial function. By further digitizing, Zetacom ensures that healthcare organizations can realize efficiency gains. This creates better care and more time and attention for patients and residents. Zetacom facilitates healthcare workers to provide care at the right place at the right time. More than 35% of all hospitals in the Netherlands use the services of Zetacom.

Zetacom has all the expertise and technical solutions in house for Communication & Collaboration, Networking & Security and Healthcare Automation & Alarming. With many years of experience as a partner in Care and Cure, Zetacom is an established name in healthcare with more than 180 employees working from the head office in Zoetermeer and branches in Den Bosch and Apeldoorn throughout the Netherlands.

About Ooperon
Ooperon supplies specialist communication solutions for the healthcare market and correctional institutions. Think of critical communication in healthcare and personal security with location determination. Reliability, safety, flexibility are important themes at Ooperon, because often – literally – human lives depend on it. Nothing can be left to chance and the products provide a guaranteed communication line, regardless of weather conditions, power failure or other calamities. Ooperon has been active for over 20 years and is seen as the market leader in the field of personal security in the judicial and healthcare market.

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2 billion across two fund strategies: Private Equity and Venture&Growth. The firm is headquartered in Utrecht (The Netherlands) with local offices in Frankfurt (Germany) and Cambridge (United States). The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers to pharma, medtech and healthcare. Gilde Healthcare’s Venture&Growth fund invests in therapeutics, medtech and healthtech in Europe and North America. Further information at

Gilde Healthcare company Ablative Solutions demonstrates Significant Reduction in Blood Pressure meeting its primary endpoint in Pivotal Trial

Ablative Solutions, Inc., announced that primary trial results from the TARGET BPI Pivotal Trial, evaluating alcohol-mediated renal denervation with the Peregrine SystemTM Kit, were presented as a Late-Breaking Clinical Trial at the American College of...
April 11, 2024

Gilde Healthcare company ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, today announced completion of enrollment of the ProVIDE pivotal clinical trial to evaluate...
March 21, 2024

Gilde Healthcare sells RAD-x to a consortium of Swiss Life Asset Managers and Vesper Infrastructure Fund I

Gilde Healthcare’s Private Equity Fund (“Gilde Healthcare”), a specialized healthcare investor, has reached a binding agreement to sell its majority stake in RAD-x to a consortium of Swiss Life Asset Managers and Vesper Next Generation...
March 18, 2024